Evolve Your Success

MAY 19, 2025

Unfiltered Medical Sales: Why Doctors Buy You Before the Product Ready to elevate your medical sales game? In the final episode of our Unfiltered Medical Sales mini series, seasoned expert Todd Crowder shares his top strategies for mastering client interactions and building lasting relationships. From choosing the right setting for a meeting to reading the emotional cues of your audience, Todd breaks down the art of creating connection wh

Medical sales 130

Medical sales Doctors Sales Medical 130

MedCity News

MAY 19, 2025

Regeneron Pharmaceuticals $256 million offer was chosen the winner of 23andMes bankruptcy auction. Drug research never became a big part of the genetic testing companys business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D. The post 23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts appeared first on MedCity News.

Pharmaceutical 254

Pharmaceutical Biopharma Pharma 254

PharmaVoice

MAY 21, 2025

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

Pharma 179

Pharma 179

Integrity Solutions

MAY 20, 2025

For most deals today, sellers aren’t just facing off against their competitors; they’re also battling a potential “no decision” scenario. In fact, some studies have shown that between 40% and 60% of deals wither on the vine, failing to close even after the customer expressed an intent to purchase. At the same time, buying cycles have grown longer and more complex, bogging down deal velocity and creating more opportunities for a buyer to reconsider or put off a decision

Sales process 130

Sales process Sales Prospecting Training 130

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

pharmaphorum

MAY 22, 2025

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity

FDA 136

FDA 136

PharmaVoice

MAY 19, 2025

HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.

182

182

PharmaTimes

MAY 19, 2025

Regulator confirms safety and efficacy of new treatment option for patient

Safety 113

Safety Patients 113

pharmaphorum

MAY 21, 2025

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

106

106

MedCity News

MAY 18, 2025

Fujirebio Diagnostics blood test for Alzheimers disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies. The post Alzheimers Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.

FDA 259

FDA Competition Medical Biopharma 259

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

PharmaVoice

MAY 19, 2025

With policies in flux, companies seek to be proactive and understand their supply chain.

147

147

Pharmaceutical Technology

MAY 22, 2025

Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year after investing an initial $40m in the company.

95

95

Evolve Your Success

MAY 19, 2025

Why Medical Device Sales? Unlock Your Power, Make a Difference If you’re looking for a career that combines high earning potential with the opportunity to make a real impact, medical device sales could be the perfect fit. In this fast- paced, dynamic industry, sales professionals help healthcare providers find the best tools and technologies to improve patient care.

Sales 130

Sales Medical Medical sales Sales process 130

MedCity News

MAY 18, 2025

As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.

Patients 249

Patients Safety 249

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaVoice

MAY 22, 2025

Turnover of the top execs at pharma giants like J&J, AbbVie and Merck in the last few years illustrates the seismic industry shifts that often accompany leadership changes.

Pharma 130

Pharma 130

pharmaphorum

MAY 22, 2025

There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer

Pharma 97

Pharma FDA 97

Pharmaceutical Technology

MAY 20, 2025

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vsendorf, Austria on 24-25 November for indepth case studies, practical workshops and highimpact networking designed to accelerate pharmas digital journey.

Pharma 86

Pharma Networking Pharmaceutical 86

MedCity News

MAY 21, 2025

Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of companies developing bispecific antibodies for those targets, many of them with molecules originally developed in China. The post Pfizer Pledges $1.25B for Drug Candidate in Promising But Competitive Area of Immunotherapy appeared first on MedCity News.

Competition 229

Competition Pharmaceutical Biopharma Pharma 229

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTimes

MAY 22, 2025

Strategic collaboration aims to improve early diagnosis

71

71

pharmaphorum

MAY 19, 2025

The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma

93

93

PharmaTech

MAY 22, 2025

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how to address an FDA warning letter citation for a failure to establish a quality control unit.

FDA 59

FDA 59

MedCity News

MAY 22, 2025

Virtual solutions for depression and anxiety can lead to clinically meaningful outcomes, but certain pricing models may increase costs for employers and health plans, according to the Peterson Health Technology Institute. The post PHTI: Digital Mental Health Solutions Work, But Can Be Costly appeared first on MedCity News.

Leads 246

Leads 246

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

PharmaTimes

MAY 22, 2025

The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first time, marking a significant step in the agencys approach to delivering health and innovation priorities across the UK.

Medicine 71

Medicine Healthcare Healthcare 71

pharmaphorum

MAY 22, 2025

Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience

91

91

Healthcare Success

MAY 19, 2025

Are you delivering the experience todays healthcare consumers actually want? You might be surprised. In this episode, Stewart Gandolf sits down with Aaron Clifford , Vice President of Consumer Experience at Press Ganey , to explore how the patient journey is evolving and how todays healthcare consumers find, evaluate, and choose providers. Drawing from Press Ganeys latest Consumer Experience Trends in Healthcare report, they explore the growing influence of AI tools, the rising importance of onl

Healthcare 65

Healthcare Healthcare Doctors Physicians 65

MedCity News

MAY 22, 2025

The Alzheimers disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofis Neuro Pipeline Expands to Alzheimers With $470M Vigil Neuroscience Acquisition appeared first on MedCity News.

Marketing 218

Marketing Biopharma Pharma 218

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

PharmaTech

MAY 21, 2025

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.

59

59

pharmaphorum

MAY 19, 2025

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal

Pharma 80

Pharma 80

Pharmaceutical Commerce

MAY 22, 2025

In a Q&A with Pharma Commerce, Kurt Lunkwitz, ProRx Pharmas COO, uncovers the stringent requirements that 503B outsourcing facilities must abide by under the Drug Quality and Security Act, while also shedding light on the FDAs impact when it comes to improving the safety, quality, and trust in compounded drugs.

Safety 69

Safety Pharma 69